China SXT Pharmaceuticals News

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(1,29%)

Aug 15 09:47 ET

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(5,42%)

May 31 10:38 ET

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(2,38%)

Feb 9 10:20 ET

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Forsakringsaktiebolaget Avanza Pension(5,07%)

Feb 9 06:39 ET

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.

Mar 29, 2023 14:19 ET

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(0%),Streeterville Management LLC(0%), etc.

Mar 29, 2023 13:48 ET

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Feb 13, 2023 16:28 ET

China SXT Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Feng Zhou(21.498%),Zhijun Xiao(20.179%)

Jan 30, 2023 16:05 ET

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.

Aug 25, 2022 15:57 ET

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Fund II LLC(9.9%), etc.

Jan 21, 2022 17:01 ET

China SXT Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 16, 2021 13:47 ET

China SXT Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 10, 2021 17:45 ET

China SXT Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 14, 2020 14:06 ET

China SXT Pharmaceuticals | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 7, 2020 15:35 ET

China SXT Pharmaceuticals | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

May 8, 2019 11:59 ET

China SXT Pharmaceuticals | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Feb 15, 2019 11:40 ET